NSRT to start Phase II trial of Eflornithine granules to treat COVID-19 by early Jan 2021 Usha Sharma Jan 3, 2021 The company aims to complete the study by March 2021
NSRT to conduct phase II trials of Eflornithine to treat COVID-19 Usha Sharma Nov 18, 2020 The trials will be conducted in four cities namely; Delhi, Lucknow, Pune, and Bengaluru and the company aims to complete the…
